These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
71 related articles for article (PubMed ID: 32602284)
1. HRM screening of the UBC9 gene encoding the SUMO-E2-conjugating enzyme - case-control study in breast cancer. Bialik P; Wysokinski D; Slomka M; Morawiec Z; Strapagiel D; Wozniak K Exp Oncol; 2020 Jun; 42(2):130-134. PubMed ID: 32602284 [TBL] [Abstract][Full Text] [Related]
2. Polymorphisms in the UBC9 and PIAS3 genes of the SUMO-conjugating system and breast cancer risk. Dünnebier T; Bermejo JL; Haas S; Fischer HP; Pierl CB; Justenhoven C; Brauch H; Baisch C; Gilbert M; Harth V; Spickenheuer A; Rabstein S; Pesch B; Brüning T; Ko YD; Hamann U Breast Cancer Res Treat; 2010 May; 121(1):185-94. PubMed ID: 19760037 [TBL] [Abstract][Full Text] [Related]
3. Polymorphism of UBC9 gene encoding the SUMO-E2-conjugating enzyme and breast cancer risk. Wozniak K; Krupa R; Synowiec E; Morawiec Z Pathol Oncol Res; 2014 Jan; 20(1):67-72. PubMed ID: 23873416 [TBL] [Abstract][Full Text] [Related]
4. Common variants in the UBC9 gene encoding the SUMO-conjugating enzyme are associated with breast tumor grade. Dünnebier T; Bermejo JL; Haas S; Fischer HP; Pierl CB; Justenhoven C; Brauch H; Baisch C; Gilbert M; Harth V; Spickenheuer A; Rabstein S; Pesch B; Brüning T; Ko YD; Hamann U Int J Cancer; 2009 Aug; 125(3):596-602. PubMed ID: 19358266 [TBL] [Abstract][Full Text] [Related]
5. Efficacy of DNA double-strand breaks repair in breast cancer is decreased in carriers of the variant allele of the UBC9 gene c.73G>A polymorphism. Synowiec E; Krupa R; Morawiec Z; Wasylecka M; Dziki L; Morawiec J; Blasiak J; Wozniak K Mutat Res; 2010 Dec; 694(1-2):31-8. PubMed ID: 20863840 [TBL] [Abstract][Full Text] [Related]
6. Ubc9 gene polymorphisms and late-onset Alzheimer's disease in the Korean population: a genetic association study. Ahn K; Song JH; Kim DK; Park MH; Jo SA; Koh YH Neurosci Lett; 2009 Nov; 465(3):272-5. PubMed ID: 19765634 [TBL] [Abstract][Full Text] [Related]
7. Both conditional ablation and overexpression of E2 SUMO-conjugating enzyme (UBC9) in mouse pancreatic beta cells result in impaired beta cell function. He X; Lai Q; Chen C; Li N; Sun F; Huang W; Zhang S; Yu Q; Yang P; Xiong F; Chen Z; Gong Q; Ren B; Weng J; Eizirik DL; Zhou Z; Wang CY Diabetologia; 2018 Apr; 61(4):881-895. PubMed ID: 29299635 [TBL] [Abstract][Full Text] [Related]
8. FOXP3 Activates SUMO-Conjugating Wang CM; Yang WH; Liu R; Wang L; Yang WH Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30011797 [TBL] [Abstract][Full Text] [Related]
9. Ubc9 sumoylation controls SUMO chain formation and meiotic synapsis in Saccharomyces cerevisiae. Klug H; Xaver M; Chaugule VK; Koidl S; Mittler G; Klein F; Pichler A Mol Cell; 2013 Jun; 50(5):625-36. PubMed ID: 23644018 [TBL] [Abstract][Full Text] [Related]
10. Site-specific inhibition of the small ubiquitin-like modifier (SUMO)-conjugating enzyme Ubc9 selectively impairs SUMO chain formation. Wiechmann S; Gärtner A; Kniss A; Stengl A; Behrends C; Rogov VV; Rodriguez MS; Dötsch V; Müller S; Ernst A J Biol Chem; 2017 Sep; 292(37):15340-15351. PubMed ID: 28784659 [TBL] [Abstract][Full Text] [Related]
11. The SUMO conjugating enzyme Ubc9 is required for inducing and maintaining stem cell pluripotency. Tahmasebi S; Ghorbani M; Savage P; Gocevski G; Yang XJ Stem Cells; 2014 Apr; 32(4):1012-20. PubMed ID: 24706591 [TBL] [Abstract][Full Text] [Related]
12. Expression analysis of Ubc9, the single small ubiquitin-like modifier (SUMO) E2 conjugating enzyme, in normal and malignant tissues. Moschos SJ; Jukic DM; Athanassiou C; Bhargava R; Dacic S; Wang X; Kuan SF; Fayewicz SL; Galambos C; Acquafondata M; Dhir R; Becker D Hum Pathol; 2010 Sep; 41(9):1286-98. PubMed ID: 20561671 [TBL] [Abstract][Full Text] [Related]
13. Genetic Polymorphism of SUMO-Specific Cysteine Proteases - SENP1 and SENP2 in Breast Cancer. Mirecka A; Morawiec Z; Wozniak K Pathol Oncol Res; 2016 Oct; 22(4):817-23. PubMed ID: 27178176 [TBL] [Abstract][Full Text] [Related]
14. Purification and activity assays for Ubc9, the ubiquitin-conjugating enzyme for the small ubiquitin-like modifier SUMO. Yunus AA; Lima CD Methods Enzymol; 2005; 398():74-87. PubMed ID: 16275321 [TBL] [Abstract][Full Text] [Related]
15. Interaction between Yi J; Wang Y; Li Q; Zhang H; Shao Z; Deng X; He J; Xiao C; Wang Z; Wang Y; Chen C J Vet Sci; 2019 Sep; 20(5):e54. PubMed ID: 31565897 [No Abstract] [Full Text] [Related]
16. Ubc9 promotes breast cell invasion and metastasis in a sumoylation-independent manner. Zhu S; Sachdeva M; Wu F; Lu Z; Mo YY Oncogene; 2010 Mar; 29(12):1763-72. PubMed ID: 20023705 [TBL] [Abstract][Full Text] [Related]
17. Spectomycin B1 as a novel SUMOylation inhibitor that directly binds to SUMO E2. Hirohama M; Kumar A; Fukuda I; Matsuoka S; Igarashi Y; Saitoh H; Takagi M; Shin-ya K; Honda K; Kondoh Y; Saito T; Nakao Y; Osada H; Zhang KY; Yoshida M; Ito A ACS Chem Biol; 2013 Dec; 8(12):2635-42. PubMed ID: 24143955 [TBL] [Abstract][Full Text] [Related]
19. A haplotype analysis of HER-2 gene polymorphisms: association with breast cancer risk, HER-2 protein expression in the tumor, and disease recurrence in Korea. Han W; Kang D; Lee JE; Park IA; Choi JY; Lee KM; Bae JY; Kim S; Shin ES; Lee JE; Shin HJ; Kim SW; Kim SW; Noh DY Clin Cancer Res; 2005 Jul; 11(13):4775-8. PubMed ID: 16000574 [TBL] [Abstract][Full Text] [Related]
20. Developmental regulation of Ubc9 in the rat nervous system. Watanabe M; Takahashi K; Tomizawa K; Mizusawa H; Takahashi H Acta Biochim Pol; 2008; 55(4):681-6. PubMed ID: 19039338 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]